Oxymorphone: A Mature Molecule with New Life – Joseph S. Gimbel, MD, Drugs of Today 44(10), 767-782, 2008.

Tapentadol Immediate Release is Associat4ed with Improved Gastrointestinal tolerability Compared with Oxycodone Immediate Release over 90 Days in Patients with Lower Back or Osteoarthritis Pain – Gimbel, J.; Oh, C.; Upmalis, D.; Okamoto, A.; Buzoianu, M.; Stegman, J., Presented at the 27^th Annual Scientific Meeting of the American Pain Society, Tampa, Fl, May 8-10, 2008.

Lidocaine Patch Treatment in Low-Back Pain Patients: Results of an Open-Lebel Non-Randomized Pilot Study- Joseph S. Gimbel, MD, et al; Journal of Pain and Symptom Management, Vol 30 no. 2, 2005

A Randomized Double-Blind Trial of Low-Dose Oxymorphone Immediate Release (5mg) for Mild to Moderate Pain in Ambulatory Patients- Dean Walker, MD, Joseph S. Gimbel, MD; Tina Ma, Ph.D; Amy Zagorski; Harry Ahdieh, Ph.D; Presentation at Annual Meeting of American Pharmacists Association, Seattle, Washington, March 26-30, 2004

Efficacy of Oxymorphone Immediate Release in Postsurgical Analgesia- Joseph S. Gimbel, MD; Harry Ahdieh, Ph.D; Submitted for Publication, Anesthesia & Analgesia

Efficacy and Safety of Oxymorphone Immediate Release for the Treatment of Mild to Moderate Pain Following Ambulatory Orthopedic Surgery: Results of a Randomized, Double-blind, Placebo-controlled Trial -Joseph S. Gimbel, MD; Tina Ma, Ph.D; Harry Ahdieh, Ph.D,; Accepted for publication, Archives of Physical Medicine and Rehabilitation

Efficacy and Safety of Oxymorphone Extended Release in Chronic Low Back Pain: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Study- Martin E. Hale, MD; Chris Dvergsten, Ph.D; Joseph S. Gimbel, MD; Submitted for Publication, Journal of the American Medical Association

Analgesic Efficacy of Parecoxib sodium for Managing Acute Pain Following Total Hip Arthroplasty - Joseph Gimbel, MD, et al; abstract presentation, 72^nd Annual Meeting of the American Academy of Orthopaedic Surgeons in Washington, DC, February 23-27, 2005

The Pharmacokinetic and Clinical Advantages of a New Immediate-Release Oral Opioid, Oxymorphone IR, for Managing Postoperative Pain- Joseph S. Gimbel, MD; and Harry Ahdieh, Ph.D; Poster Presentation at Annual Meeting of the Academy of Managed Care Pharmacy; San Francisco, California, March 31-April 2, 2004

Lidocaine Patch 5% Effectively Treats Neuropathic Pain Qualities in Low-Back Pain: Results of a 6-Week, Prospective, Open-Label Trial- Arnold R. Gammaitoni, Ph.D; Joseph S. Gimbel, MD; Martin Hale, MD; Richard Linn, MD; Bradley S. Galer, MD; Poster Pain Society, Vancouver, BC, Canada, May 6-9, 2004

Low-Dose Oxymorphone Immediate Release (5mg) for Mild to Moderate Pain Following Arthroscopic Knee Surgery in Ambulatory Patients: A Randomized Double-Blind Trial- Joseph Gimbel, MD; Wendy M. Lee, RMA,CRC; Tina Ma, Ph.D; Amy Zagorski; Harry Ahdieh, Ph.D; Poster Presentation at the Annual Meeting of the American Academy of Nurse Practitioners, New Orleans, Louisiana, June 13-15, 2004

Impact of Treatment with the Lidocaine Patch 5% on Pain Qualities Reported by Patients with Low Back Pain: A 6-Week, Prospective, Open-Label Study- Arnold R. Gammaitoni, PhD.; Joseph Gimbel, MD; Martin Hale, MD; Richard Linn, MD; Bradley S. Galer, MD; Poster Presentation, American Academy of Physical Medicine and Rehabilitation, Phoenix, Arizona, October 7-10, 2004

Effectiveness of Lidocaine Patch 5% on Reducing the Intensity of Neuropathic Pain Qualities Reported by Low Back Pain Patients- Arnold Gammaitoni, Ph.D; Joseph Gimbel, MD; Martin Hale, MD; Richard Linn, MD; Roland Onawala, Ph.D, MPH, Bradley Galer, MD; Nancy Alvarez, Ph.D; Poster Presentation at the Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, Phoenix, Arizona, October 7-10, 2004

Oxymorphone Immediate Release for Postsurgical Pain: Translating Pharmacokinetic Drug Properties Into Clinical Efficacy- Joseph S. Gimbel, MD; Michael P. Adams, Ph.D; Poster Presentation at Annual Meeting of American College of Surgeons, New Orleans, Louisiana, October 11-14-2004

Impact of Treatment with the Lidocaine Patch 5% on Pain Qualities Reported by Patients with Low Back Pain: A 6-Week, Prospective, Open-Label Study- Arnold R. Gammaitoni, PhD; Joseph Gimbel, MD; Martin Hale, MD; Richard Linn, MD; Bradley S. Galer, MD; Poster Presentation, Annual Meeting of American College of Nurse Practitioners, Philadelphia, Pennsylvania, October 20-24, 2004

Analgesic Efficacy of Valdecoxib 40 mg qd in the Management of Acute Pain Following Anterior Cruciate Ligament Reconstruction - E. F. Ekman, MD, J. S. Gimbel, MD, H. Williams, MD, Ph.D, D. Y. Shapiro, MD, K. M. Verburg, Ph.D., presentation at Annual Meeting of the American Society of Anesthesiologists, Las Vegas, Nevada, October 23-27, 2004

Controlled-Release Oxycodone for Pain in Diabetic Neuropathy:  A Randomized Controlled Trial - Joseph Gimbel, MD; Patricia Richards, MD, PhD; Ellen W. McCroskery, MD; Russell K. Portenoy, MD; Journal of Neurology, Volume 60, Number 6, pp927-934, March 25, 2003

Impact of the Lidocaine Patch 5% on Quality of Life When Used in Combination With Gabapentin in Three Chronic Pain States - Joseph Gimbel, MD; Bradley S. Galer, MD; Martin Hale, MD; Richard Linn, MD; Elizabeth Kurkimilis, CRA; Arnold R. Gammaitoni, PharmD; Poster Presented at the 22^nd Annual Meeting of the American Pain Society - March 20-23, 2003

Lidocaine Patch 5% in Patients With Acute/Subacute and Chronic Low Back Pain: Impact on Pain Intensity, Pain Relief, and Pain Interference With Quality of Life - Joseph Gimbel, MD; Martin Hale, MD; Richard Linn, MD; Bradley S. Galer, MD; Elizabeth Kurkimilis, CRA; Arnold R. Gammaitoni, PharmD; Poster Presented at the 22^nd Annual Meeting of the American Pain Society - March 20-23, 2003